BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 11297957)

  • 1. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study.
    Imbert-Bismut F; Ratziu V; Pieroni L; Charlotte F; Benhamou Y; Poynard T;
    Lancet; 2001 Apr; 357(9262):1069-75. PubMed ID: 11297957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.
    Myers RP; Ratziu V; Imbert-Bismut F; Charlotte F; Poynard T;
    Am J Gastroenterol; 2002 Sep; 97(9):2419-25. PubMed ID: 12358267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients.
    Myers RP; Benhamou Y; Imbert-Bismut F; Thibault V; Bochet M; Charlotte F; Ratziu V; Bricaire F; Katlama C; Poynard T
    AIDS; 2003 Mar; 17(5):721-5. PubMed ID: 12646795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and comparison of indexes for fibrosis and cirrhosis prediction in chronic hepatitis C patients: proposal for a pragmatic approach classification without liver biopsies.
    Bourliere M; Penaranda G; Renou C; Botta-Fridlund D; Tran A; Portal I; Lecomte L; Castellani P; Rosenthal-Allieri MA; Gerolami R; Ouzan D; Deydier R; Degott C; Halfon P
    J Viral Hepat; 2006 Oct; 13(10):659-70. PubMed ID: 16970597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrotest-Actitest: the biochemical marker of liver fibrosis--the Israeli experience.
    Morali G; Maor Y; Klar R; Braun M; Ben Ari Z; Bujanover Y; Zuckerman E; Boger S; Halfon P
    Isr Med Assoc J; 2007 Aug; 9(8):588-91. PubMed ID: 17877064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease.
    Ratziu V; Massard J; Charlotte F; Messous D; Imbert-Bismut F; Bonyhay L; Tahiri M; Munteanu M; Thabut D; Cadranel JF; Le Bail B; de Ledinghen V; Poynard T; ;
    BMC Gastroenterol; 2006 Feb; 6():6. PubMed ID: 16503961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
    Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
    J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C.
    Sebastiani G; Halfon P; Castera L; Mangia A; Di Marco V; Pirisi M; Voiculescu M; Bourliere M; Alberti A
    Aliment Pharmacol Ther; 2012 Jan; 35(1):92-104. PubMed ID: 22035045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of FIBROSpect II to detect hepatic fibrosis in chronic hepatitis C patients.
    Zaman A; Rosen HR; Ingram K; Corless CL; Oh E; Smith K
    Am J Med; 2007 Mar; 120(3):280.e9-14. PubMed ID: 17349453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Usefulness of a novel serum proteome-derived index FI-PRO (fibrosis-protein) in the prediction of fibrosis in chronic hepatitis C.
    Cheung KJ; Tilleman K; Deforce D; Colle I; Moreno C; Gustot T; Van Vlierberghe H
    Eur J Gastroenterol Hepatol; 2011 Aug; 23(8):701-10. PubMed ID: 21623191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accuracy of simple biochemical tests in identifying liver fibrosis in patients co-infected with human immunodeficiency virus and hepatitis C virus.
    Tural C; Tor J; Sanvisens A; Pérez-Alvarez N; Martínez E; Ojanguren I; García-Samaniego J; Rockstroh J; Barluenga E; Muga R; Planas R; Sirera G; Rey-Joly C; Clotet B
    Clin Gastroenterol Hepatol; 2009 Mar; 7(3):339-45. PubMed ID: 19171202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective comparison of Fibroscan, King's score and liver biopsy for the assessment of cirrhosis in chronic hepatitis C infection.
    Cross TJ; Calvaruso V; Maimone S; Carey I; Chang TP; Pleguezuelo M; Manousou P; Quaglia A; Grillo F; Dhillon AP; Dusheiko GM; Burroughs AK; Harrison PM
    J Viral Hepat; 2010 Aug; 17(8):546-54. PubMed ID: 19874477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnostic value of serum biochemical markers for liver fibrosis in patients with hepatitis B virus].
    Huang W; Gong FY
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Nov; 22(11):1034-6. PubMed ID: 12433643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The FibroTest value in discriminating between insignificant and significant fibrosis in chronic hepatitis C patients. The Romanian experience.
    Grigorescu M; Rusu M; Neculoiu D; Radu C; Serban A; Catanas M; Grigorescu MD
    J Gastrointestin Liver Dis; 2007 Mar; 16(1):31-7. PubMed ID: 17410286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between liver biopsy and fibrotest in the evaluation of hepatic fibrosis in patients with chronic hepatitis C.
    Said Y; Salem M; Mouelhi L; Mekki H; Houissa F; Ben Rejeb M; Moussa A; Trabelsi S; Debbeche R; Bouzaidi S; Najjar T
    Tunis Med; 2010 Aug; 88(8):573-8. PubMed ID: 20711964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepascore: an accurate validated predictor of liver fibrosis in chronic hepatitis C infection.
    Adams LA; Bulsara M; Rossi E; DeBoer B; Speers D; George J; Kench J; Farrell G; McCaughan GW; Jeffrey GP
    Clin Chem; 2005 Oct; 51(10):1867-73. PubMed ID: 16055434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Fibrotest and PGAA for the diagnosis of fibrosis stage in patients with alcoholic liver disease.
    Naveau S; Essoh BM; Ghinoiu M; Marthey L; Njiké-Nakseu M; Balian A; Lachgar M; Prévot S; Perlemuter G
    Eur J Gastroenterol Hepatol; 2014 Apr; 26(4):404-11. PubMed ID: 24561990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FibroScore for the non-invasive assessment of liver fibrosis in chronic viral hepatitis.
    Ashraf S; Ahmed SA; Ahmed J; Ali N
    J Coll Physicians Surg Pak; 2012 Feb; 22(2):84-90. PubMed ID: 22313643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Independent prospective multicenter validation of biochemical markers (fibrotest-actitest) for the prediction of liver fibrosis and activity in patients with chronic hepatitis C: the fibropaca study.
    Halfon P; Bourliere M; Deydier R; Botta-Fridlund D; Renou C; Tran A; Portal I; Allemand I; Bertrand JJ; Rosenthal-Allieri A; Rotily M; Sattonet C; Benderitter T; Saint Paul MC; Bonnot HP; Penaranda G; Degott C; Masseyeff MF; Ouzan D
    Am J Gastroenterol; 2006 Mar; 101(3):547-55. PubMed ID: 16542291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibro-α score as a simple and useful non-invasive test for predicting significant liver fibrosis in chronic hepatitis C patients.
    Omran MM; Farid K; Emran TM; Attallah AA
    Arab J Gastroenterol; 2011 Jun; 12(2):74-9. PubMed ID: 21684477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.